Immunologic aspects of preterm labor.
Mitchell
M D
MD
Department of Obstetrics and Gynecology, University of Utah, Salt Lake City.
Branch
D W
DW
Lundin-Schiller
S
S
Romero
R J
RJ
Daynes
R A
RA
Dudley
D J
DJ
D000650:Amnion / Q000187:drug effects / Q000378:metabolism; D016718:Arachidonic Acid / Q000494:pharmacology; D002821:Chorioamnionitis / Q000150:complications / Q000276:immunology / Q000378:metabolism; D016207:Cytokines / Q000096:biosynthesis / Q000502:physiology; D015232:Dinoprostone / Q000096:biosynthesis / Q000502:physiology; D005260:Female; D006801:Humans; D007375:Interleukin-1 / Q000502:physiology; D015850:Interleukin-6 / Q000494:pharmacology; D016209:Interleukin-8 / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000276:immunology; D007752:Obstetric Labor, Premature / Q000276:immunology*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects / Q000378:metabolism
D016207:Cytokines; D007375:Interleukin-1; D015850:Interleukin-6; D016209:Interleukin-8; D008070:Lipopolysaccharides; D014409:Tumor Necrosis Factor-alpha; D016718:Arachidonic Acid; D015232:Dinoprostone; D013755:Tetradecanoylphorbol Acetate